Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06374277 · ClinicalTrials.gov registry record · NA

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

A NA study of Depression and Hypertension, sponsored by University of Tennessee.

Recruiting
Registry status
NA
Development phase
388
Enrollment target
2
Study locations

NCT06374277 is a NA study of Depression and Hypertension that is actively recruiting participants, run by University of Tennessee. The registered enrollment target is 388 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06374277, a NA study of Depression and Hypertension, is actively recruiting participants, sponsored by University of Tennessee.

RECRUITING
Registry status
NA
Development phase
388 participants
Enrollment target
2
Study locations

Study Summary

Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of readmissions and costs among these patients. Major patient-reported barriers to essential medication use after hospital discharge among low-income individuals are related to social determinants of health (SDOH) and include: 1) financial barriers , 2) transportation barriers, and 3) system-level barriers. Although, medication therapy management services are important during care transitions, these services have not proven effective in improving medication adherence after hospital discharge, highlighting a critical need for innovative interventions. The Medication Affordability, Accessibility, and Availability in Care Transitions (Med AAAction) Study will test the effectiveness of a pharmacy-led care transitions intervention versus usual care through a pragmatic randomized controlled trial of 388 Medicaid and uninsured hospital in-patients with MCC from three large healthcare systems in Tennessee. The intervention will involve: 1) medications with zero copay, 2) bedside delivery then home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up. We will examine the impact of the intervention during 12 months on 1) medication adherence (primary outcome) and 2) rapid primary care follow-up, 30-day readmissions, hospitalizations and emergency department visits, and costs. We will conduct key informant interviews to understand patient experience with the acre received during and after care transitions. By examining effectiveness of the intervention on outcomes including medication adherence, health care utilization, costs, an

Interventions

  • OTHER Med AAAction intervention

Study Locations (2)

Tennessee

  • University of Tennessee Medical Center - Knoxville
  • University of Tennessee Health Science Center/Regional One Health - Memphis

Trial Details

FieldValue
Enrollment Target 388 participants
Start Date 2024-04-06
Est. Completion 2028-01-31
Phase NA

Sponsor

University of Tennessee

96 total trials

What the Registry Record Tells You About NCT06374277

The ClinicalTrials.gov registry entry for NCT06374277 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (51% lower). The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Med AAAction intervention is the first listed.

NCT06374277 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06374277 about?

NCT06374277 is a clinical study titled "Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence". Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of re...

What is the current status of trial NCT06374277?

This trial is currently recruiting. It is a NA study. The enrollment target is 388 participants. The study started on 2024-04-06. Estimated completion is 2028-01-31.

What conditions does trial NCT06374277 study?

This clinical trial studies the following conditions: Depression, Hypertension, Stroke, Diabetes, Coronary Artery Disease.

What interventions are being tested in trial NCT06374277?

The interventions under investigation include: Med AAAction intervention (OTHER).

Who is sponsoring clinical trial NCT06374277?

This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06374277 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.